参考文献/References:
[1].Masy MGiordano J,Petyt G,et al. Dual-energy (DECT) lung perfusion in pulmonary hypertension:concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH)[J]. Eur Radiol,2018,28(12):5100-5110.
[2].Schü?ler A,Richter M,Tello K,et al. Evaluation of diagnostic accuracy and radiation exposure of dual-energy computed tomography (DECT) in the course of chronic thromboembolic pulmonary hypertension (CTEPH)[J]. RoFo,2021,193(11):1318-1326?.
[3].Mileto A,Ananthakrishnan L,Morgan DE,et al. Clinical implementation of dual-energy CT for gastrointestinal imaging[J]. AJR Am J Roentgenol,2021,217(3):651-663.
[4].Agostini A,Borgheresi A,Mari A,et al. Dual-energy CT:theoretical principles and clinical applications[J]. Radiol Med,2019,124(12):1281-1295.
[5].Lee CW,Seo JB,Song JW,et al. Evaluation of computeraideddetec inanddual energy soft wareindetecti nofperipheral pulmonary embolismon dual-energy pulmonary CT angiography[J]. Eur Radiol,2011,21(2):54-62.
[6].Bridgford L. Pulmonary embolism:assessment and imaging[J]. Aust Fam Physician,2014,43(5):249.
[7].Celtikci P,Hekimoglu K,Kahraman G,et al. Diagnostic impact of quantitative dual-energy computed tomography perfusion imaging for the assessment of subsegmental pulmonary embolism[J]. J Comput Assist Tomogr,2021,45(1):151-156.
[8].Ozawa Y,Ohno Y,Nagata H,et al. Advances for pulmonary functional imaging:dual-energy computed tomography for pulmonary functional imaging[J]. Diagnostics (Basel),2023,13(13):2295.
[9].Essien EO,Rali P,Mathai SC. Pulmonary Embolism[J]. Med Clin North Am,2019,103(3):549-564.
[10].Weidman EK,Plodkowski AJ,Halpenny DF,et al. Dual-energy CT angiography for detection of pulmonary emboli:incremental benefit of iodine maps[J].Radiology,2018,289(2):546-553.
[11].Monti CB,Zanardo M,Cozzi A,et al. Dual-energy CT performance in acute pulmonary embolism:a meta-analysis[J]. Eur Radiol,2021,31(8):6248-6258.
[12].Abdellatif W,Ebada MA,Alkanj S,et al. Diagnostic accuracy of dual-energy CT in detection of acute pulmonary embolism:a systematic review and meta-analysis[J]. Can Assoc Radiol J,2021,72(2):285-292.
[13].Sueyoshi E,Tsutsui S,Hayashida T,et al. Quantification of lung perfusion blood volume (lung PBV) by dual-energy CT in patients with and without pulmonary embolism:preliminary results[J]. Eur J Radiol,2011,80(3):e505-e509.
[14].Sakamoto A,Sakamoto I,Nagayama H,et al. Quantification of lung perfusion blood volume with dual-energy CT:assessment of the severity of acute pulmonary thromboembolism[J]. AJR Am J Roentgenol,2014,203(2):287-291.
[15].Takx RAP,Henzler T,Schoepf UJ,et al. Predictive value of perfusion defects on dual energy CTA in the absence of thromboembolic clots[J]. J Cardiovasc Comput Tomogr,2017,11(3):183-187.
[16].Apfaltrer P,Bachmann V,Meyer M,et al. Prognostic value of perfusion defect volume at dual energy CTA in patients with pulmonary embolism:correlation with CTA obstruction scores,CT parameters of right ventricular dysfunction and adverse clinical outcome[J]. Eur J Radiol,2012,81(11):3592-3597.
[17].Foldyna B,Zangeneh FA,Wagner M,et al. Pulmonary perfusion defect volume on dual-energy CT:prognostic marker of adverse events in patients with suspected pulmonary embolism[J]. Int J Cardiovasc Imaging,2023,39(7):1333-1341.
[18].Yan L,Li X,Liu Z,et al. Research progress on the pathogenesis of CTEPH[J]. Heart Fail Rev,2019,24(6):1031-1040.
[19].Gall H,Hoeper MM,Richter MJ,et al. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA,Europe and Japan[J]. Eur Respir Rev,2017,26(143):160121.
[20].Yang S,Yang Y,Zhai Z,et al. Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism[J]. J Thorac Dis,2015,7(11):1927-1938.
[21].Lewczuk J,Piszko P,Jagas J,et al. Prognostic factors in medically treated patients with chronic pulmonary embolism[J]. Chest,2001,119(3):818-823.
[22].McLaughlin VV, Langer A, Tan M,et al. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension:an initiative to close the care gap[J]. Chest,143(2):324-332.
[23].Dournes G,Verdier D,Montaudon M,et al. Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension:diagnostic accuracy and concordance with radionuclide scintigraphy[J]. Eur Radiol,2014,24(1):42-51.
[24].Renard B,Remy-Jardin M,Santangelo T,et al. Dual-energy CT angiography of chronic thromboembolic disease:can it help recognize links between the severity of pulmonary arterial obstruction and perfusion defects? [J]. Eur J Radiol,2011,79(3):467-472.
[25].Abozeed M,Conic S,Bullen J,et al. Dual energy CT based scoring in chronic thromboembolic pulmonary hypertension and correlation with clinical and hemodynamic parameters:a retrospective cross-sectional study[J]. Cardiovasc Diagn Ther,2022,12(3):305-313.
[26].Takagi H,Ota H,Sugimura K,et al. Dual-energy CT to estimate clinical severity of chronic thromboembolic pulmonary hypertension:Comparison with invasive right heart catheterization[J]. Eur J Radiol,2016,85(9):1574-1580.?
[27].Lorenz G,Saeedan MB,Bullen J,et al. CT-based biomarkers for prediction of chronic thromboembolic pulmonary hypertension after an acute pulmonary embolic event[J]. AJR Am J Roentgenol,2020,215(4):800-806.
[28].Giordano J,Khung S,Duhamel A,et al. Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH):dual-energy CT experience in 31 patients[J]. Eur Radiol,2017,27(4):1631-1639.
[29].Seferian A,Helal B,Ja?s?X,et al. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease[J]. Eur Respir J,2012,40(1):75-83.
[30].Lefebvre B,Kyheng M,Giordano J,et al. Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH):preliminary experience in 63 patients[J]. Eur Radiol,2022,32(7):4574-4586.
相似文献/References:
[1]朱洪基,余建群,彭礼清.心电门控双源CTPA评价急性肺栓塞及其右心室功能[J].心血管病学进展,2019,(6):955.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.029]
ZHU Hongji,YU Jianqun,PENG Liqing.Evaluation of Acute Pulmonary Embolism and Its Right Ventricular Function by ECG Gated Dual-source CTPA[J].Advances in Cardiovascular Diseases,2019,(1):955.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.029]
[2]张鹏 刘金波 王宏宇.静脉血栓栓塞症患者血浆生物标志物与肺栓塞的相关性研究[J].心血管病学进展,2022,(4):365.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.019]
ZHANG Peng,LIU Jinbo,WANG Hongyu.Correlation Between Plasma Biomarkers and Pulmonary Embolism in?atients with Venous Thromboembolism[J].Advances in Cardiovascular Diseases,2022,(1):365.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.019]
[3]朱栋 何翔 李国平.基于Virchow三要素浅谈环境污染与肺栓塞疾病[J].心血管病学进展,2022,(11):984.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.005]
ZHU Dong,HE Xiang,LI Guoping.Discussing Environmental Pollution and Pulmonary Embolic Disease Based on?irchows Triad[J].Advances in Cardiovascular Diseases,2022,(1):984.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.005]
[4]李梦依 刘英杰 齐灵垚 秦地茂.孟德尔随机化探讨三甲胺N-氧化物及其前体与静脉血栓栓塞的因果关系[J].心血管病学进展,2023,(8):764.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.020]
Li Mengyi,Liu YingjieQi LingyaoQin Dimao.Mendelian Randomization Exploring the Causality of Trimethylamine N-oxide and Its Precursors with Venous Thromboembolism[J].Advances in Cardiovascular Diseases,2023,(1):764.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.020]
[5]王一佳 黄志华 高璐阳 赵智慧 赵青 罗勤 柳志红.人工智能在肺血管疾病诊治中的研究进展[J].心血管病学进展,2024,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.002]
WANG Yijia,HUANG Zhihua,GAO Luyang,et al.Artificial Intelligence in Diagnosis and Treatment of Pulmonary Vascular Diseases[J].Advances in Cardiovascular Diseases,2024,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.002]
[6]焦小净 龚娟妮 邝土光 李积凤 张一笑 杨媛华.慢性阻塞性肺疾病急性加重期合并肺栓塞的患病率及临床特征分析[J].心血管病学进展,2024,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.021]
JIAO Xiaojing,G ONG Juanni,K UANG Tuguang,et al.Incidence Rate and Clinical Characteristics of Pulmonary Embolism in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Advances in Cardiovascular Diseases,2024,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.021]